Advertisement

Genes & Genomics

, Volume 40, Issue 4, pp 381–388 | Cite as

Correlation of IGF1R expression with ABCG2 and CD44 expressions in human osteosarcoma

  • Cheung-Kue Kim
  • Sunju Oh
  • Sook-Ja Kim
  • Sun-Hee Leem
  • Jeonghoon Heo
  • So-Hak Chung
Research Article
  • 124 Downloads

Abstract

Osteosarcoma is the most common type of malignant bone tumors. Insulin Growth Factor 1 receptor (IGFR1) has been known as a prognostic factor for metastasis of osteosarcoma. ABC subfamily G member2 (ABCG2) is related to resistance to anti-cancer drug, and CD44 has a role in tumor growth and metastasis. The purpose of this study is to investigate the relationship among expression patterns of IGF1R, ABCG2, and CD44 in osteosarcoma. The expression levels of IGF1R, ABCG2, and CD44 proteins were determined in tissue arrays containing osteosarcoma tissues from 59 osteosarcoma patients. The expression pattern of IGF1R was highly correlated with the expression pattern of ABCG2 (r = 0.88) in overall osteosarcoma patients. According to pathological types, the expression pattern of IGF1R showed the higher correlation with ABGC2 (r = 0.90) and CD44 (r = 0.61) in osteoblatic type than in chondroblastic type. According to gender with pathologic type, the correlation between the expression patterns of IGF1R and CD44 was higher in male with osteoblatic type than in female with osteoblatic type. Among different age groups, the 1–10 years age group showed higher correlation in IGF1R versus CD44 (r = 0.90) and ABCG2 versus CD44 (0.80) than in other age groups. These results showed that the expression of IGF1R appears to be highly correlated with the expression of ABCG2 in osteosarcoma and with the expression of CD44 in osteosarcoma patients under age of 10, which suggests that ABCG2 and CD44 can be used as prognostic factors with IGF1R for specific prognosis and efficient treatment of osteosarcoma.

Keywords

Osteosarcoma IGF1R ABCG2 CD44 Prognostic factor Correlation 

Notes

Compliance with ethical standards

Conflict of interest

Cheung-Kue Kim, Sunju Oh, Sook-Ja Kim, Sun-Hee Leem, Jeonghoon Heo and So-Hak Chung decleare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human subjects or animals performed by any of the authors.

Supplementary material

13258_2017_639_MOESM1_ESM.docx (3.2 mb)
Supplementary material 1 (DOCX 3227 KB)

References

  1. Ajani JA, Song S, Hochster HS, Steinberg IB (2015) Cancer stem cells; the promise and the potential. Semin Oncol Suppl 1:S3–S7CrossRefGoogle Scholar
  2. Al-Hajj M, Wicha MS, Benito-Hernandez B, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983–3988CrossRefPubMedPubMedCentralGoogle Scholar
  3. Brenton JD, Carey LA, Ahmed AA, Caldas C (2005) Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23:7350–7360CrossRefPubMedGoogle Scholar
  4. Cao Y, Roth M, Piperdi S, Montoya K, Sowers R, Rao P, Geller D, Houghton P, Kolb EA, Gill J, Gorlick R (2014) Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma. PLOs ONE 9:e106249CrossRefPubMedPubMedCentralGoogle Scholar
  5. Gillet JP, Gottesman MM (2010) Mechanism of multidrug resistance in cancer. Methods Mol Biol 596:47–76CrossRefPubMedGoogle Scholar
  6. Gvozdenovic A, Arlt MJ, Campanile C, Brennecke P, Husmann K, Li Y (2013) CD44 enhance tumor formation and lung metastastis in experimental osteosarcoma and is an additional predictor for poor patient outcome. J Bone Miner Res 28:838–847CrossRefPubMedGoogle Scholar
  7. Han I, Lee MR, Kim HS (2014) The role of CTGF in osteosarcoma progression. J Kor Bone Joint Tumor Soc 20:1–6CrossRefGoogle Scholar
  8. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kormblum HI (2003) Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100:15178–15183CrossRefPubMedPubMedCentralGoogle Scholar
  9. Heyse TJ, Malcherczyk D, Moll R, Timmesfeld N, Wapelhorst J, Fuchs-Winkelmann S, Paletta JR, Schofer MD (2010) CD44: survival and metastasis in chondrosarcoma. Osteoarthr Cartil 18:849–856CrossRefPubMedGoogle Scholar
  10. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U (2004) A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101:14228–14233CrossRefPubMedPubMedCentralGoogle Scholar
  11. Hirschmann-Jax C, Foster AE, Wulf GG, Goodell MA, Brenner MK (2005) A distinct side population of cells in human tumor cells: implication for tumor biology and therapy. Cell Cycle 4:203–205CrossRefPubMedGoogle Scholar
  12. Jentzsch T, Robl B, Husmann M, Bode-Lesniewska B, Fuchs B (2014) Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray. Anticancer Res 34:3881–3889PubMedGoogle Scholar
  13. Liang SC, Yand CY, Tseng JY, Wang HL, Tung CY, Liu HW, Chen CY (2015) ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cell. Neoplasia 17:265–278CrossRefPubMedPubMedCentralGoogle Scholar
  14. Liu Y, Wu Y, Gu S, Sun Z, Rui Y, Wang J, Lu Y, Li H, Xu K, Sheng P (2014) Prognositic role of CD44 expression in osteosarcoma: evidence from six studies. Diagn Pathol 9:140CrossRefPubMedPubMedCentralGoogle Scholar
  15. Liu Y, Teng Z, Wang Y, Gao P, Chen J (2015) Prognostic significance of survivin expression in osteosarcoma patients: a meta-analysis. Med Sci Monit 21:2877–2885CrossRefPubMedPubMedCentralGoogle Scholar
  16. Massard C, Deutsch E, Soria JC (2006) Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol 17:1620–1624CrossRefPubMedGoogle Scholar
  17. Naor D, Sinov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71:241–319CrossRefPubMedGoogle Scholar
  18. Polyak K, Hahn WC (2006) Roots and stems: stem cells in cancer. Nat Med 12:296–300CrossRefPubMedGoogle Scholar
  19. Saini V, Hose CD, Monks A, Nagashima K, Han B, Newton DL, Millione A, Shah J, Hollingshead MG, Hite KM, Burkett MW, Delosh RM, Silvers TE, Scudiero DA, Shoemaker RH (2012) Identification of CBX3 and ABCA5 as puative biomarkers for tumor stem cell in osteosarcoma. PLoS ONE 7:e41401CrossRefPubMedPubMedCentralGoogle Scholar
  20. Siclari VA, Qin L (2010) Targeting the Osteosarcoma cancer stem cell. J Orthop Surg Res 5:78CrossRefPubMedPubMedCentralGoogle Scholar
  21. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D (2006) Ovarian cancer side population defines cells with stem cell like characteristics and mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 103:11154–11159CrossRefPubMedPubMedCentralGoogle Scholar
  22. Uribe-Botero G, Russell WO, Sutow WW, Martin RG (1977) Primary osteosarcoma of bone: clinicopathologic investigation of 243cases, with necropsy studies in 54. Am J Clin Pathol 65:427–435CrossRefGoogle Scholar
  23. Veselska R, Skoda J, Neradil J (2012) Detection of cancer stem cell markers in sarcomas. Klin Onkol 25(Suppl 2):2S16-2S20Google Scholar
  24. Walters DK, Steinmann P, Langsam B, Schmutz S, Born W (2008) Identification of potential chemoresistance genes in osteosarcoma. Anticancer Res 28:673–680PubMedGoogle Scholar
  25. Wang LL (2005) Biology of osteogenic sarcoma. Cancer J 11:294–305CrossRefPubMedGoogle Scholar
  26. Wang YH, Wang ZX, Qiu Y, Xiong J, Chen YX, Miao DS, De W (2009) Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells. Mol Cell Biochem 327:257–266CrossRefPubMedGoogle Scholar
  27. Wang YH, Han XD, Qiu Y, Xiong J, Yu Y, Wang B, Zhu ZZ, Qian BP, Chen YX, Wang SF, Shi HF, Sun X (2012) Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma. J Surg Oncol 105:235–243CrossRefPubMedGoogle Scholar
  28. Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea a paradigm shift. Cancer Res 66:1883–1890CrossRefPubMedGoogle Scholar

Copyright information

© The Genetics Society of Korea and Springer Science+Business Media B.V., part of Springer Nature 2017

Authors and Affiliations

  1. 1.Department of Orthopedic Surgery, College of MedicineKosin University, Gospel HospitalBusanSouth Korea
  2. 2.Department of Orthopedic SurgeryKyung Hee University Hospital at GangdongSeoulSouth Korea
  3. 3.Department of Pathology, College of MedicineKosin UniversityBusanSouth Korea
  4. 4.Institute for Medical ScienceKosin UniversityBusanSouth Korea
  5. 5.Department of Biological ScienceDong-A UniversityBusanSouth Korea
  6. 6.Department of Molecular Biology and Immunology, College of MedicineKosin UniversityBusanSouth Korea

Personalised recommendations